The ETS-domain transcription factor family
The DOI matches its Crossref record; 116 of the 116 references it cites were found in a registry or an index.
Abstract
ETS-domain transcription-factor networks represent a model for how combinatorial gene expression is achieved. These transcription factors interact with a multitude of co-regulatory partners to elicit gene-specific responses and drive distinct biological processes. These proteins are controlled by a complex series of inter and intramolecular interactions, and signalling pathways impinge on these proteins to further regulate their action.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The resulting phosphorylation regulates the TCF proteins at the levels of DNA binding, coactivator or -repressor recruitment, and cellular localization (2, 88, 91, 111).”
From Genomic and biochemical insights into the specificity of ETS transcription factors (2011) · cites this paper as [2]
In the citing paper
“ETS proteins display a variety of such cooperative partnerships, as previously reviewed (1, 2, 151, 152).”
From Genomic and biochemical insights into the specificity of ETS transcription factors (2011) · cites this paper as [2]
Citations
Cites
Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages
Scott, E. W., Simon, M. C., Anastasi, J., & Singh, H. (1994) · Science · doi:10.1126/science.8079170 · Cited by 1,532
The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain
Marais, R., Wynne, J., & Treisman, R. (1993) · Cell · doi:10.1016/0092-8674(93)90237-k · Cited by 1,275
Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities
McKercher, S. R., Torbett, B. E., Anderson, K. L., Henkel, G. W., Vestal, D. J., Baribault, H., Klemsz, M., Feeney, A. J., Wu, G. E., Paige, C. J., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00949.x · Cited by 1,130
Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF
Jacobs, J. J. L., Scheijen, B., Voncken, J.-W., Kieboom, K., Berns, A., & van Lohuizen, M. (1999) · Genes & Development · doi:10.1101/gad.13.20.2678 · Cited by 1,065
Gille, H., Sharrocks, A. D., & Shaw, P. E. (1992) · Nature · doi:10.1038/358414a0 · Cited by 954
Self-citationIntegration of MAP Kinase Signal Transduction Pathways at the Serum Response Element
Whitmarsh, A. J., Shore, P., Sharrocks, A. D., & Davis, R. J. (1995) · Science · doi:10.1126/science.7618106 · Cited by 932
Self-citationA TEL-JAK2 Fusion Protein with Constitutive Kinase Activity in Human Leukemia
Lacronique, V., Boureux, A., Della Valle, V., Poirel, H., Quang, C. T., Mauchauffé, M., Berthou, C., Lessard, M., Berger, R., Ghysdael, J., et al. (1997) · Science · doi:10.1126/science.278.5341.1309 · Cited by 791
Regulation of B lymphocyte and macrophage development by graded expression of PU.1
DeKoter, R. P., & Singh, H. (2000) · Science · doi:10.1126/science.288.5470.1439 · Cited by 749 · cited 1×
“1, with high levels promoting macrophage differentiation and low levels inducing the B-cell fat”
BackgroundTernary complex factors: growth factor regulated transcriptional activators
Treisman, R. (1994) · Current Opinion in Genetics & Development · doi:10.1016/0959-437x(94)90097-3 · Cited by 676
O'Neill, E. M., Rebay, I., Tjian, R., & Rubin, G. M. (1994) · Cell · doi:10.1016/0092-8674(94)90580-0 · Cited by 675
Cited by
Items 101–200 of 1,000
Boros, J., Donaldson, I. J., O'Donnell, A., Odrowaz, Z. A., Zeef, L., Lupien, M., Meyer, C. A., Liu, X. S., Brown, M., & Sharrocks, A. D. (2009) · Genome Research · doi:10.1101/gr.093047.109 · Cited by 127
Self-citationEts-1, a functional cofactor of T-bet, is essential for Th1 inflammatory responses
Grenningloh, R., Kang, B. Y., & Ho, I.-C. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041330 · Cited by 127
“Ets-1 (E26 transformation–specific-1) is the prototype of the ETS family of transcription factors, which are characterized by a conserved ETS domain that is capable of binding to DNA sequences containing a core GGAA/T motif (16, 17).”
BackgroundERG induces taxane resistance in castration-resistant prostate cancer
Galletti, G., Matov, A., Beltran, H., Fontugne, J., Mosquera, J. M., Cheung, C., MacDonald, T. Y., Sung, M. S., O'Toole, S. A., Kench, J. G., et al. (2014) · Nature Communications · doi:10.1038/ncomms6548 · Cited by 138
“…in DU145-GFP cells transiently transfected with flag-tagged ERG expression vectors encoding either wild type TMRPSS2-ERG (encoding truncated ERG) or tiling deletion mutants 10 that are devoid of key functional domains (e.g. pointed (PNT), CAE/CD, transactivating or ETS DNA binding 33,34 , Fig.”
Albino, D., Longoni, N., Curti, L., Grand, M. M., Pinton, S., Civenni, G., Thalmann, G. N., D’Ambrosio, G., Sarti, M., Sessa, F., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0212 · Cited by 142
“ETS transcription factors are important elements in differentiation and developmental programs in many tissues and their expression is tightly regulated according to specific tissue- and timedependent patterns (14, 15).”
Genome-wide prediction of cis-regulatory regions using supervised deep learning methods
Li, Y., Shi, W., & Wasserman, W. W. (2018) · BMC Bioinformatics · doi:10.1186/s12859-018-2187-1 · Cited by 125
“These TFs regulate general cellular progresses such as differentiation, proliferation, or apoptosis [47, 48].”
BackgroundHegen, A., Koidl, S., Weindel, K., Marmé, D., Augustin, H. G., & Fiedler, U. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000140819.81839.0e · Cited by 123
Zhou, X., & O'Shea, E. K. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.05.025 · Cited by 120
“However, these factors frequently regulate distinct biological responses (Robinson and Lopes, 2000; Sharrocks, 2001).”
Advances in Ewing's Sarcoma Research: Where Are We Now and What Lies Ahead?
Ordóñez, J. L., Osuna, D., Herrero, D., de Álava, E., & Madoz‐Gúrpide, J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4041 · Cited by 122
Pusl, T., Wu, J. J., Zimmerman, T. L., Zhang, L., Ehrlich, B. E., Berchtold, M. W., Hoek, J. B., Karpen, S. J., Nathanson, M. H., & Bennett, A. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203002200 · Cited by 120
Transcriptional regulation of hepatic stellate cells
Mann, J., & Mann, D. A. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.03.011 · Cited by 119
“tion with other transcriptional activators, in particular AP-1 proteins [78,79].”
BackgroundIwamoto, M., Tamamura, Y., Koyama, E., Komori, T., Takeshita, N., Williams, J. A., Nakamura, T., Enomoto-Iwamoto, M., & Pacifici, M. (2007) · Developmental Biology · doi:10.1016/j.ydbio.2007.01.037 · Cited by 118
“…specificity is provided by interactions with other transcription factors (Verger et al., 2001; Verger and Duterque-Coquillaud, 2002), phosphorylation and conformational changes consequent to interactions with other factors (Papoutsopolou and Janknecht, 2000; Sharrocks, 2001; Yang et al., 2001).”
InfluentialRole for ETS domain transcription factors Pea3/Erm in mouse lung development
Liu, Y., Jiang, H., Crawford, H. C., & Hogan, B. L. M. (2003) · Developmental Biology · doi:10.1016/s0012-1606(03)00359-2 · Cited by 128
“The subfamily has been implicated in various cellular processes, including proliferation , differentiation, and tumorigenesis (Bartel et al., 2000; Maroulakou and Bowe, 2000; Sharrocks, 2001).”
BackgroundRizzo, F. M., Fernandez-Serra, M., Squarzoni, P., Archimandritis, A., & Arnone, M. I. (2006) · Developmental Biology · doi:10.1016/j.ydbio.2006.08.012 · Cited by 126
“An initial BLASTN homology search through the deposited unassembled traces, followed by analyses of contigs and scaffolds later, was conducted using the ETS DNA binding domain (the “ETS domain”; Graves and Petersen, 1998 )o f human genes representative of all ETS subgroups (Laudet et al., 1999; Sharrocks, 2001 ).Seque…”
BackgroundMethodInfluentialShape-specific recognition in the structure of the Vts1p SAM domain with RNA
Oberstrass, F. C., Lee, A., Štefl, R., Janis, M., Chanfreau, G., & Allain, F. H. ‐. (2006) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1038 · Cited by 123
“For example, the SAM domain of the transcription activator ETS-1 provides a docking site for the mitogen-activated protein (MAP) kinase ERK2, which phosphorylates ETS-1 (ref”
BackgroundBarrett, L. E., Sul, J., Takano, H., Bockstaele, E. J. V., Haydon, P. G., & Eberwine, J. H. (2006) · Nature Methods · doi:10.1038/nmeth885 · Cited by 131
“6 ), which is known to be involved in differentiatio”
Phan, V. T., Wu, X., Cheng, J. H., Sheng, R. X., Chung, A. S., Zhuang, G., Tran, C., Song, Q., Kowanetz, M., Sambrone, A., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303302110 · Cited by 116
“The Ets proteins are important for many cellular processes, including cell proliferation, apoptosis, hematopoiesis, angiogenesis, and tumorigenesis (16).”
BackgroundInfluentialOn the road to immortality: hTERT upregulation in cancer cells
Janknecht, R. (2004) · FEBS Letters · doi:10.1016/s0014-5793(04)00356-4 · Cited by 116
EGR1 and the ERK‐ERF axis drive mammary cell migration in response to EGF
Tarcic, G., Avraham, R., Pines, G., Amit, I., Shay, T., Lu, Y., Zwang, Y., Katz, M., Ben‐Chetrit, N., Jacob‐Hirsch, J., et al. (2012) · The FASEB Journal · doi:10.1096/fj.11-194654 · Cited by 115
“The major candidate group of such TFs comprises the 26 members of the ETS family, which undergo rapid phosphorylation in response to activation of various MAPKs (32).”
BackgroundThe Ets transcription factors of the PEA3 group: Transcriptional regulators in metastasis
de Launoit, Y., Baert, J., Chotteau‐Lelièvre, A., Monté, D., Coutte, L., Mauën, S., Firlej, V., Degerny, C., & Verreman, K. (2006) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.02.002 · Cited by 129
Janknecht, R. (2003) · Oncogene · doi:10.1038/sj.onc.1206185 · Cited by 123
“This transcription factor belongs to the ETS class of proteins that are characterized by a conserved DNAbinding domain mediating contact to sites with a 50-GGAA/T-3 0 core sequence (Graves and Petersen, 1998; Sharrocks, 2001).”
BackgroundSpatially Separate Docking Sites on ERK2 Regulate Distinct Signaling Events In Vivo
Dimitri, C. A., Dowdle, W., MacKeigan, J. P., Blenis, J., & Murphy, L. O. (2005) · Current Biology · doi:10.1016/j.cub.2005.06.037 · Cited by 114
“ERK2 dock to and activate the Ets family transcription factor Elk-1 [ 19 ], leading to induction of specific IEGs.”
Ras, Akt, and Mechanotransduction in the Cardiac Myocyte
Sugden, P. H. (2003) · Circulation Research · doi:10.1161/01.res.0000106132.04301.f5 · Cited by 132
Boccuni, P., MacGrogan, D., Scandura, J. M., & Nimer, S. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300592200 · Cited by 114
Predictive biomarkers for cancer therapy with PARP inhibitors
Michels, J., Vitale, I., Saparbaev, M. K., Castedo, M., & Kroemer, G. (2013) · Oncogene · doi:10.1038/onc.2013.352 · Cited by 124
Yan, J., Erdem, H., Li, R., Cai, Y., Ayala, G., Ittmann, M., Yu‐Lee, L., Tsai, S. Y., & Tsai, M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0955 · Cited by 117
“First, using an oligonucleotide probe containing AP-1 binding site, electrophoretic mobility shift assays (EMSA) showed DNA-protein complexes in the nuclear extract of the PC3 cells (Supplementary Fig.”
InfluentialWang, J. Q., Tang, Q., Parelkar, N. K., Liu, Z., Samdani, S., Choe, E. S., Yang, L., & Mao, L. (2004) · Molecular Neurobiology · doi:10.1385/mn:29:1:01 · Cited by 113
17β-Estradiol inhibits matrix metalloproteinase-2 transcription via MAP kinase in fibroblasts
Mahmoodzadeh, S., Dworatzek, E., Fritschka, S., Pham, T. H., & Regitz-Zagrosek, V. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvp350 · Cited by 112
“binding of phosphorylated Elk-1 promotes the recruitment of co-repressors.(46) Yang et al.”
Birsoy, K., Berry, R., Wang, T., Ceyhan, O., Tavazoie, S., Friedman, J. M., & Rodeheffer, M. S. (2011) · Development · doi:10.1242/dev.067710 · Cited by 111
“As none of these factors has previously been implicated in adipogenesis or WAT mass regulation (Sharrocks, 2001; Tymms and Kola, 1994; Watabe et al., 1998), we next set out to analyze the expression and function of the three candidate transcription factors that are known to bind CCGGAG, NRF2/GABPA,…”
BackgroundArticular Cartilage: Structural and Developmental Intricacies and Questions
Decker, R. S., Koyama, E., & Pacifici, M. (2015) · Current Osteoporosis Reports · doi:10.1007/s11914-015-0290-z · Cited by 137
Global gene expression analysis of human erythroid progenitors
Merryweather-Clarke, A. T., Atzberger, A., Soneji, S., Gray, N., Clark, K., Waugh, C., McGowan, S. J., Taylor, S., Nandi, A. K., Wood, W. G., et al. (2011) · Blood · doi:10.1182/blood-2010-07-290825 · Cited by 106
An Induced Ets Repressor Complex Regulates Growth Arrest during Terminal Macrophage Differentiation
Klappacher, G., Lunyak, V. V., Sykes, D. B., Sawka‐Verhelle, D., Sage, J., Brard, G., Ngo, S. D., Gangadharan, D., Jacks, T., Kamps, M. P., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00714-6 · Cited by 125
Sümegi, J., Nishio, J., Nelson, M., Frayer, R. W., Perry, D. A., & Bridge, J. A. (2010) · Modern Pathology · doi:10.1038/modpathol.2010.201 · Cited by 111
Epstein-Barr virus LMP1 blocks p16INK4a–RB pathway by promoting nuclear export of E2F4/5
Ohtani, N., Brennan, P., Gaubatz, S., Sanij, E., Hertzog, P., Wolvetang, E., Ghysdael, J., Rowe, M., & Hara, E. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200302085 · Cited by 104
“Both Ets2 and E2F5 do not contain typical NES sequences (Boulukos et al., 1989; Graves and Petersen, 1998; Ducret et al., 1999; Gaubatz et al., 2001; Sharrocks, 2001).”
BackgroundNakerakanti, S. S., Kapanadze, B., Yamasaki, M., Markiewicz, M., & Trojanowska, M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600466200 · Cited by 109
SLFN11 Is a Transcriptional Target of EWS-FLI1 and a Determinant of Drug Response in Ewing Sarcoma
Tang, S.-W., Bilke, S., Cao, L., Murai, J., Sousa, F. G., Yamade, M., Rajapakse, V., Varma, S., Helman, L. J., Khan, J., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2112 · Cited by 103
“FLI1 is a member of the family of ETS transcription factors containing a highly conserved domain that recognizes ETS core consensus sites (GGAA/T); the flanking DNA sequence providing the affinity and specificity (12, 13).”
BackgroundWu, R., Ayhan, A., Maeda, D., Kim, K.-R., Clarke, B. A., Shaw, P. H., Chui, M. H., Rosen, B. P., Shih, I., & Wang, T. (2014) · The Journal of Pathology · doi:10.1002/path.4315 · Cited by 108
“In addition, several ETS-domain transcription factors are activated by mitogen-activated protein kinase (MAPK), which is commonly up-regulated in cancer cells [28].”
BackgroundDown-Regulation of DUSP6 Expression in Lung Cancer
Okudela, K., Yazawa, T., Woo, T., Sakaeda, M., Ishii, J., Mitsui, H., Shimoyamada, H., Sato, H., Tajiri, M., Ogawa, N., et al. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080489 · Cited by 118
CXCL13-CXCR5 axis: Regulation in inflammatory diseases and cancer
Wang, B., Wang, M., Ao, D., & Wei, X. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188799 · Cited by 127
SIMON, L., Ekman, G. C., Tyagi, G., HESS, R., MURPHY, K., & Cooke, P. S. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.05.002 · Cited by 101
“[9] A.”
BackgroundDifferentiation of core promoter architecture between plants and mammals revealed by LDSS analysis
Yamamoto, Y. Y., Ichida, H., Abe, T., Suzuki, Y., Sugano, S., & Obokata, J. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm685 · Cited by 101
Wu, X., Goodyear, S. M., Tobias, J. W., Avarbock, M. R., & Brinster, R. L. (2011) · Biology of Reproduction · doi:10.1095/biolreprod.111.091793 · Cited by 100
Carbone, G. M. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh744 · Cited by 100
F-box protein interactions with the hallmark pathways in cancer
Randle, S. J., & Laman, H. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.09.013 · Cited by 114
“Other examples, include Elk1, which was originally idenified as a TF downstream of ERK signalling, which subsequently p-regulates, for example, the proto-OG c-Fos [100].”
BackgroundThoms, J. A. I., Birger, Y., Foster, S., Knezevic, K., Kirschenbaum, Y., Chandrakanthan, V., Jonquieres, G., Spensberger, D., Wong, J. W., Oram, S. H., et al. (2011) · Blood · doi:10.1182/blood-2010-12-317990 · Cited by 99
Transcriptional Regulation of EGR-1 by the Interleukin-1-JNK-MKK7-c-Jun Pathway
Hoffmann, E., Ashouri, J., Wolter, S., Doerrie, A., Dittrich-Breiholz, O., Schneider, H., Wagner, E. F., Troppmair, J., Mackman, N., & Kracht, M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800583200 · Cited by 96
Regulation of endothelial cell development by ETS transcription factors
Meadows, S. M., Myers, C. T., & Krieg, P. A. (2011) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2011.09.009 · Cited by 107
Wu, J., & Janknecht, R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205501200 · Cited by 95
Goel, A., & Janknecht, R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400036200 · Cited by 95
BRAF Mutations: Signaling, Epidemiology, and Clinical Experience in Multiple Malignancies
Hall, R. D., & Kudchadkar, R. R. (2014) · Cancer Control · doi:10.1177/107327481402100307 · Cited by 93
Otero, M., Plumb, D. A., Tsuchimochi, K., Dragomir, C. L., Hashimoto, K., Peng, H., Olivotto, E., Bevilacqua, M., Tan, L., Yang, Z., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.265744 · Cited by 101
Mitogen-induced recruitment of ERK and MSK to SRE promoter complexes by ternary complex factor Elk-1
Zhang, H.-M., Li, L., Papadopoulou, N., Hodgson, G., Evans, E., Galbraith, M., Dear, M., Vougier, S., Saxton, J., & Shaw, P. E. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn099 · Cited by 93
Derepression by Depolymerization
Qiao, F., Song, H., Kim, C. A., Sawaya, M. R., Hunter, J. B., Gingery, M., Rebay, I., Courey, A. J., & Bowie, J. U. (2004) · Cell · doi:10.1016/j.cell.2004.07.010 · Cited by 92
Human autoinflammatory disease reveals ELF4 as a transcriptional regulator of inflammation
Tyler, P. M., Bucklin, M. L., Zhao, M., Maher, T. J., Rice, A. J., Ji, W., Warner, N. E., Pan, J., Morotti, R. A., McCarthy, P. L., et al. (2021) · Nature Immunology · doi:10.1038/s41590-021-00984-4 · Cited by 101
Nur77 is phosphorylated in cells by RSK in response to mitogenic stimulation
Wingate, A. D., Campbell, D. G., Peggie, M., & Arthur, J. S. C. (2006) · Biochemical Journal · doi:10.1042/bj20050967 · Cited by 91
Elevated β1,4-Galactosyltransferase I in Highly Metastatic Human Lung Cancer Cells
Zhu, X., Jiang, J., Shen, H., Wang, H., Zong, H., Li, Z., Yang, Y., Niu, Z., Liu, W., Chen, X., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m413631200 · Cited by 91
Paakinaho, V., Kaikkonen, S., Makkonen, H., Benes, V., & Palvimo, J. J. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1033 · Cited by 90
From keys to bulldozers: expanding roles for winged helix domains in nucleic-acid-binding proteins
Harami, G. M., Gyimesi, M., & Kovács, M. (2013) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2013.04.006 · Cited by 90
Dynamic regulation of VEGF-inducible genes by an ERK-ERG-p300 transcriptional network
Fish, J. E., Gutierrez, M. E. C., Dang, L. T. H., Khyzha, N., Chen, Z., Veitch, S., Cheng, H. S., Khor, M., Antounians, L., Njock, M., et al. (2017) · Development · doi:10.1242/dev.146050 · Cited by 103
“ETS factors bind to a consensus 5′-GGA(A/ T)-3′ sequence in the genome through a highly conserved ∼85 amino acid ETS domain (Sharrocks, 2001).”
BackgroundTranscriptional regulation of telomerase activity: Roles of the the Ets transcription factor family
DWYER, J., LI, H., XU, D., & LIU, J. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1396.022 · Cited by 77
Orth, M. F., Surdez, D., Faehling, T., Ehlers, A. C., Marchetto, A., Grossetête, S., Volckmann, R., Zwijnenburg, D. A., Gerke, J. S., Zaïdi, S., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111761 · Cited by 92
“As expected from the similar molecular architecture and conserved C-terminal DNA-binding domains of these EWSR1-ETS fusions, 5,72 we noted a large and highly significant overlap in DEGs and corresponding GSEA outputs at the mRNA and protein levels of 23%–41% (p < 0.001 for both; Figures 3A-3D).”
InfluentialStructural Analysis of the Autoinhibition of Ets-1 and Its Role in Protein Partnerships
Garvie, C. W., Pufall, M. A., Graves, B. J., & Wolberger, C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206327200 · Cited by 86
Roles of Pim‐3, a novel survival kinase, in tumorigenesis
Mukaida, N., Wang, Y., & Li, Y. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.01966.x · Cited by 91
Tyagi, G., Carnes, K. I., Morrow, C. M. K., Kostereva, N. V., Ekman, G. C., Meling, D. D., Hostetler, C. E., Griswold, M. D., MURPHY, K. M. M., Hess, R. A., et al. (2009) · Biology of Reproduction · doi:10.1095/biolreprod.108.075200 · Cited by 89
“The ets proteins have roles in many biological processes, including cell proliferation, differentiation, apoptosis, immune response and oncogenic transformation, lung development, and epithelial-mesenchymal interactions [26–28].”
BackgroundWang, Y., Wang, K., Hu, Z., Zhou, H., Zhang, L., Wang, H., Li, G., Zhang, S., Cao, X., & Shi, F. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-1153-1 · Cited by 88
Complexity in Transcription Control at the Activation Domain–Mediator Interface
Balamotis, M. A., Pennella, M. A., Stevens, J. L., Wasylyk, B., Belmont, A. S., & Berk, A. J. (2009) · Science Signaling · doi:10.1126/scisignal.1164302 · Cited by 84
Baillat, D., Bègue, A., Stéhelin, D., & Aumercier, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200088200 · Cited by 84
Molecular mechanisms of megakaryopoiesis
Szalai, G., LaRue, A. C., & Watson, D. K. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-006-6190-8 · Cited by 125
Transient receptor potential TRPM3 channels: Pharmacology, signaling, and biological functions
Thiel, G., Rubil, S., Lesch, A., Guethlein, L. A., & Rößler, O. G. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.07.014 · Cited by 83
Val, S. D., Anderson, J. P., Heidt, A. B., Khiem, D., Xu, S.-M., & Black, B. L. (2004) · Developmental Biology · doi:10.1016/j.ydbio.2004.08.016 · Cited by 88
“As such, Ets factors in the vasculature and in other lineages function in combination with other transcription factors to mediate lineage-specific transcription (Sharrocks, 2001; Verger and DuterqueCoquillaud, 2002).”
BackgroundAlterations of Gene Expression in the Development of Early Hyperplastic Precursors of Breast Cancer
Lee, S., Medina, D., Tsimelzon, A. I., Mohsin, S. K., Mao, S., Wu, Y., & Allred, D. C. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.061010 · Cited by 82
Ets-dependent Regulation of Target Gene Expression during Megakaryopoiesis
Jackers, P., Szalai, G., Moussa, O., & Watson, D. K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407489200 · Cited by 91
Kishi, M., Kummer, T. T., Eglen, S. J., & Sanes, J. R. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200411012 · Cited by 80
“13), is a member of a large family of “Ets-domain” transcriptional regulators (Sharrocks, 2001).”
BackgroundZhou, N., Liu, K., Sun, Y., Cao, Y., & Yang, J. (2019) · Protein & Cell · doi:10.1007/s13238-018-0599-3 · Cited by 81
“Bioinformatics suggested this composite motif as the potential binding site of the ETS (E26 transformation-specific) family of transcription factors (Sharrocks, 2001; Hollenhorst et al., 2011).”
BackgroundRoles and regulations of the ETS transcription factor ELF4/MEF
Suico, M. A., Shuto, T., & Kai, H. (2016) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjw051 · Cited by 87
“The E26 transformation-specific (ETS) transcription factors are recognized as having an 85-amino acid DNA-binding domain—the ETS domain—that binds to the DNA sequence 5′-GGA(A/T)-3′, and are evolutionarily conserved throughout the metazoa (Sharrocks, 2001).”
BackgroundTargeting chromatin complexes in fusion protein-driven malignancies
Brien, G. L., Stegmaier, K., & Armstrong, S. A. (2019) · Nature reviews. Cancer · doi:10.1038/s41568-019-0132-x · Cited by 86
Autism-Associated Haplotype Affects the Regulation of the Homeobox Gene, ENGRAILED 2
Benayed, R., Choi, J., Matteson, P. G., Gharani, N., Kamdar, S., Brzustowicz, L. M., & Millonig, J. H. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.05.027 · Cited by 81
Sperone, A., Dryden, N. H., Birdsey, G. M., Madden, L., Johns, M., Evans, P. C., Mason, J. C., Haskard, D. O., Boyle, J. J., Paleolog, E. M., et al. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.216473 · Cited by 81
Ross, K. A., Smyth, N. A., Murawski, C. D., & Kennedy, J. G. (2013) · ISRN Oncology · doi:10.1155/2013/759725 · Cited by 85
“Preclinical evidence suggests the utility of molecular therapies for Ewing sarcoma.”
BackgroundNelson, K. K., Subbaram, S., Connor, K. M., Dasgupta, J., Ha, X.-F., Meng, T.-C., Tonks, N. K., & Melendez, J. A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601820200 · Cited by 79
Ets2 is necessary in trophoblast for normal embryonic anteroposterior axis development
Georgiades, P., & Rossant, J. (2006) · Development · doi:10.1242/dev.02277 · Cited by 89
“Ets2, which encodes a member of the Ets family of nuclear transcription factors (Sharrocks, 2001), was shown to be expressed exclusively in PPT during the period of embryonic patterning, and Ets2 mutant embryos were reported to show reduced growth of the EPC and to lack the chorion, the derivative…”
BackgroundInterplay among transcription factors Ets21c, Fos and Ftz-F1 drives JNK-mediated tumor malignancy
Külshammer, E., Mundorf, J., Kilinc, M., Frommolt, P., Wagle, P., & Uhlirova, M. (2015) · Disease Models & Mechanisms · doi:10.1242/dmm.020719 · Cited by 65
“TFs of the ETS-domain family are key regulators of development and homeostasis in all metazoans, whereas their aberrant activity has been linked with cancer (Sharrocks, 2001).”
InfluentialA dosage-dependent role for Spry2 in growth and patterning during palate development
Welsh, I. C., Hagge-Greenberg, A., & O’Brien, T. P. (2007) · Mechanisms of Development · doi:10.1016/j.mod.2007.06.007 · Cited by 91
“The ETS family of signal-dependent transcription factors are known to mediate FGF/RTK signaling and their activity is regulated by phosphorylation by MAPK (Sharrocks, 2001).”
BackgroundRegulation of angiogenesis by ETS transcription factors
RANDI, A. M., Sperone, A., Dryden, N. H., & Birdsey, G. M. (2009) · Biochemical Society Transactions · doi:10.1042/bst0371248 · Cited by 84
ROGER, T., MICONNET, I., SCHIESSER, A.-L., KAI, H., MIYAKE, K., & CALANDRA, T. (2005) · Biochemical Journal · doi:10.1042/bj20041243 · Cited by 79
Postnatal Gene Expression in the Normal Mouse Cornea by SAGE
Norman, B., Davis, J. A., & Piatigorsky, J. (2004) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.03-0449 · Cited by 82
“Ets factors are important in the transcriptional regulation of genes involved in diverse biological functions.(98,99) Among the six ets family members found in this study, four are enriched in the cornea.”
BackgroundWang, Y., Ding, X., Liu, B., Li, M., Chang, Y., Shen, H., Xie, S. M., Xing, L., & Li, Y. (2019) · Molecular Carcinogenesis · doi:10.1002/mc.23130 · Cited by 84
Gaillard, E., Bruck, N., Brelivet, Y., Bour, G., Lalevée, S., Bauer, A., Poch, O., Moras, D., & Rochette-Egly, C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509717103 · Cited by 76
Transcription factors Elk-1 and SRF are engaged in IL1-dependent regulation of ZC3H12A expression
Kasza, A., Wyrzykowska, P., Horwacik, I., Tymoszuk, P., Mizgalska, D., Palmer, K., Rokita, H., Sharrocks, A. D., & Jura, J. (2010) · BMC Molecular Biology · doi:10.1186/1471-2199-11-14 · Cited by 81
Self-citationEtv2 as an essential regulator of mesodermal lineage development
Koyano‐Nakagawa, N., & Garry, D. J. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvx133 · Cited by 80
Transcriptional control of B cell development and function
Bartholdy, B., & Matthias, P. (2003) · Gene · doi:10.1016/j.gene.2003.11.008 · Cited by 92
HMGB 1 mediates hyperglycaemia‐induced cardiomyocyte apoptosis via ERK /Ets‐1 signalling pathway
Wang, W., Lu, Q., Zhang, J., Wang, B., Liu, X., An, F., Qin, W., Chen, X., Dong, W., Zhang, C., et al. (2014) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12399 · Cited by 75
“Ets-1 is a transcription factor, controlling cell growth, proliferation, differentiation and apoptosis [15].”
BackgroundNagai, N., Ohguchi, H., Nakaki, R., Matsumura, Y., Kanki, Y., Sakai, J., Aburatani, H., & Minami, T. (2018) · PLOS Genetics · doi:10.1371/journal.pgen.1007826 · Cited by 75
Ets21c Governs Tissue Renewal, Stress Tolerance, and Aging in the Drosophila Intestine
Mundorf, J., Donohoe, C. D., McClure, C. D., Southall, T. D., & Uhlířová, M. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.05.025 · Cited by 91
“…factors of the E-twenty six (ETS) family are functionally conserved in all metazoans and are implicated in a plethora of processes, including cell-cycle control, differentiation, proliferation, apoptosis, and tissue remodeling (Hollenhorst et al., 2011; Sharrocks, 2001; Slack et al., 2015).”
BackgroundJin, X., Chen, X., Hu, Y., Ying, F., Zou, R., Lin, F., Shi, Z., Zhu, X., Yan, X., Shi, L., et al. (2017) · Cancer Medicine · doi:10.1002/cam4.1084 · Cited by 75
“Our study indicated that ELK1 is a nuclear target for the rasrafMAPK signaling cascade [45].”
BackgroundNOTCH-1 and NOTCH-4 are novel gene targets of PEA3 in breast cancer: novel therapeutic implications
Clementz, A. G., Rogowski, A., Pandya, K., Miele, L., & Osipo, C. (2011) · Breast Cancer Research · doi:10.1186/bcr2900 · Cited by 74
“PEA3 contains an ETS winged helix-turn-helix DNA binding motif [41] that binds to the canonical sequence GGAA/T on target genes [42].”
BackgroundThe ERK MAP kinase-PEA3/ETV4-MMP-1 axis is operative in oesophageal adenocarcinoma
Keld, R. R., Guo, B., Downey, P., Gulmann, C., Ang, Y. S., & Sharrocks, A. D. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-313 · Cited by 76
Self-citationAlbino, D., Civenni, G., Dallavalle, C., Roos, M. M., Jahns, H., Curti, L., Rossi, S., Pinton, S., D’Ambrosio, G., Sessa, F., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2665 · Cited by 74
“How does Lin28 let-7 control development and disease? Trends Cell Biol 2012;22(9):474-82.”
BackgroundThe transcription factor Net regulates the angiogenic switch
Zheng, H., Wasylyk, C., Ayadi, A., Abecassis, J., Schalken, J. A., Rogatsch, H., Wernert, N., Maira, S.-M., Multon, M.-C., & Wasylyk, B. (2003) · Genes & Development · doi:10.1101/gad.272503 · Cited by 79
“MAP kinases phosphorylate nuclear effectors, such as members of the ets family of transcription factors (Sharrocks 2001).”
BackgroundSperm nuclear proteome and its epigenetic potential
Castillo, J., Amaral, A., & Oliva, R. (2013) · Andrology · doi:10.1111/j.2047-2927.2013.00170.x · Cited by 82
“Interestingly, proteins containing erythroblast transformation-specific domains, which are involved in developmental processes, have been identified in mature spermatozoa (Table S1) (Hsu & Schulz, 2000; Sharrocks, 2001).”
BackgroundZamisch, M., Tian, L., Grenningloh, R., Xiong, Y., Wildt, K. F., Ehlers, M., Ho, I.-C., & Bosselut, R. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20092024 · Cited by 73
Metadata
- Authors
- Sharrocks, A. D.
- Affiliations
- University of Manchester (GB)
- Corresponding author
- Sharrocks, Andrew D.
- ORCID
- Sharrocks, Andrew D.
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2001-11
- Volume
- 2
- Issue
- 11
- Pages
- 827-837
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W1606273823
- Semantic Scholar
- 85f56e9a6533d13eb04056b206cd450ddf1fd9dd
- Cited by
- 1,086
- References
- 116
- Citations by year
- 2026: 22 · 2025: 30 · 2024: 46 · 2023: 43 · 2022: 24 · 2021: 38 · 2020: 35 · 2019: 40 · 2018: 35 · 2017: 48 · 2016: 52 · 2015: 49 · 2014: 35 · 2013: 47 · 2012: 43
- FWCI
- 3.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene Regulatory Network Analysis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- ETS transcription factors, transcriptional regulatory networks, combinatorial gene expression, protein-protein interaction, intramolecular interactions, signaling pathways, gene expression regulation
- MeSH terms
- Animals, DNA, Multigene Family, Humans, Models, Biological, Models, Molecular, Neoplasms, Phosphorylation, Protein Binding, Proto-Oncogene Proteins, Transcription Factors, Protein Structure, Tertiary, Proto-Oncogene Proteins c-ets
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.